Page results
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
-
This information has been written for parents and carers whose child is having radiotherapy treatment to the whole lungs. The page explains the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the testes.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the chest, or mediastinum.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to a part of the brain. This page breaks down the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer